Gyula Szücs

Title: Innovations by Gyula Szücs: Exploring 8-Chloro-2,3-Benzodiazepine Derivatives

Introduction

Gyula Szücs is a prominent inventor based in Budapest, Hungary. He has made significant contributions to the field of pharmacology, particularly with his innovative work on benzodiazepine derivatives.

Latest Patents

Szücs holds a patent for 8-chloro-2,3-benzodiazepine derivatives. This invention pertains to new compounds characterized by the general formula (I), where R denotes a lower alkyl group or —NH—R' (with R' as a lower alkyl or cycloalkyl group). The patent also includes the pharmaceutically acceptable acid addition salts thereof. Furthermore, it describes a process for preparing these compounds, pharmaceutical compositions that incorporate them, and new intermediates beneficial for synthesizing the 8-chloro-2,3-benzodiazepine derivatives. Notably, the invented compounds exhibit AMPA/kainate receptor inhibiting activity, which can have significant implications in medicinal chemistry.

Career Highlights

Gyula Szücs currently operates at Egis Gyógyszergyár Rt., a well-known pharmaceutical company dedicated to developing innovative medications. His work reflects a commitment to advancing therapeutic solutions through the exploration of new chemical entities.

Collaborations

Throughout his career, Szücs has collaborated with notable colleagues, including Jozsef Barkoczy and Istvan Ling. Working alongside such talented individuals indicates a flourishing environment for innovation and research at Egis Gyógyszergyár Rt.

Conclusion

Gyula Szücs's contributions to the field of pharmaceuticals through his patent on 8-chloro-2,3-benzodiazepine derivatives highlight the importance of innovation in medical science. His work not only signifies advancements in treatment options but also establishes a foundation for future research in receptor inhibition and pharmacology.